Pancreatic cancer patients without imaging evidence of peritoneal metastasis
Conditions
Interventions
Lavage cytology using EUS-FNA
Sponsors
Aichi Cancer Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients aged greater than or equal to 20 years at the time of informed consent. 2. Patients who have provided written informed consent. 3. Patients with an ECOG Performance Status of 0 or 1. 4. Patients diagnosed with pancreatic cancer without apparent peritoneal dissemination on imaging, regardless of the presence of distant metastases other than peritoneal dissemination, provided that conversion surgery may be considered. 5. Patients considered eligible for safe performance of EUS-FNA.
Exclusion criteria
Exclusion criteria: 1. Patients with another active malignancy under treatment. 2. Patients with moderate or greater ascites or detectable peritoneal nodules. 3. Patients with a history of upper gastrointestinal surgery. 4. Patients considered inappropriate for this study at the discretion of the treating physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The positivity rate of peritoneal lavage cytology using this procedure | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety Procedure success rate Prognosis | — |
Countries
Japan
Contacts
Public ContactNozomi Okuno
Aichi Cancer Center Department of Gastroenterology
Outcome results
None listed